
Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16th, 2018
Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16th, 2018
DNA Molecular Taggants: A Hidden Key to Pharmaceutical Patient Safety
October 12th, 2018
Applied DNA appoints new textiles chief
October 4th, 2018
APDN Appoints Wayne Buchen VP of Strategic Sales for Textile Vertical
October 4th, 2018
Videojet, APDN Join for Supply Chain Security, Counterfeit Prevention
October 3rd, 2018
LineaRx Secures New RNA Therapeutics Customers for Contract Research Services
October 1st, 2018
International Partners Looking To Grow Pot-Tagging Biz
September 28th, 2018
Applied DNA Expands Its Cannabis Tagging Portfolio to Address Large Growers
September 25th, 2018
Counterfeiting is on the Rise, Consumers Will Boycott Inauthentic Brands
September 24th, 2018